NM
Nirmal Mukherjee
About Nirmal Mukherjee
Data last updated:
Nirmal Mukherjee is an Additional Director at Sanctus Drugs & Pharmaceuticals Pvt Ltd (since 2025). The company operates in Pharma. Sanctus Drugs & Pharmaceuticals Pvt Ltd reported revenue of ₹8.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanctus Drugs & Pharmaceuticals Pvt Ltd U24232MP1984PTC002519 | Additional Director | 27 Oct 2025 | ₹8.50 Cr (FY 2025) | Active |
Board colleagues of Nirmal Mukherjee
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rahul Jain | 08775759 | Sanctus Drugs & Pharmaceuticals Pvt Ltd | Director |
| Sanjay Jain | 00322404 | Sanctus Drugs & Pharmaceuticals Pvt Ltd | Director |
| Sumit Kumar Agarwal | 00574338 | Sanctus Drugs & Pharmaceuticals Pvt Ltd | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Mukherjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Mukherjee
Nirmal Mukherjee currently holds 1 directorship: Sanctus Drugs & Pharmaceuticals Pvt Ltd (Additional Director, since 27 Oct 2025, revenue ₹8.50 Cr (FY 2025)).
Nirmal Mukherjee was first appointed on 27 Oct 2025 as Additional Director at Sanctus Drugs & Pharmaceuticals Pvt Ltd.
The current boards of Nirmal Mukherjee's companies include Rahul Jain (Sanctus Drugs & Pharmaceuticals Pvt Ltd), Sanjay Jain (Sanctus Drugs & Pharmaceuticals Pvt Ltd), Sumit Kumar Agarwal (Sanctus Drugs & Pharmaceuticals Pvt Ltd).